![Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies | Nature Reviews Neurology Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies | Nature Reviews Neurology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrneurol.2017.162/MediaObjects/41582_2018_Article_BFnrneurol2017162_Fig3_HTML.jpg)
Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies | Nature Reviews Neurology
![A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease | Nature Reviews Neurology A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease | Nature Reviews Neurology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41582-018-0116-6/MediaObjects/41582_2018_116_Fig1_HTML.png)
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease | Nature Reviews Neurology
![Leveraging preclinical models for the development of Alzheimer disease therapeutics.,Nature Reviews Drug Discovery - X-MOL Leveraging preclinical models for the development of Alzheimer disease therapeutics.,Nature Reviews Drug Discovery - X-MOL](https://xpic.x-mol.com/20200409%2F10.1038_s41573-020-0065-9.png)
Leveraging preclinical models for the development of Alzheimer disease therapeutics.,Nature Reviews Drug Discovery - X-MOL
![A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain | Nature Reviews Neurology A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain | Nature Reviews Neurology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrneurol.2017.111/MediaObjects/41582_2017_Article_BFnrneurol2017111_Fig1_HTML.jpg)
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain | Nature Reviews Neurology
![Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies | Nature Reviews Neurology Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies | Nature Reviews Neurology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrneurol.2017.162/MediaObjects/41582_2018_Article_BFnrneurol2017162_Fig1_HTML.jpg)
Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies | Nature Reviews Neurology
![Frontiers | Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease | Neuroscience Frontiers | Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease | Neuroscience](https://www.frontiersin.org/files/MyHome%20Article%20Library/328460/328460_Thumb_400.jpg)